Accelerating discovery of safer chemicals and precision medicine for neurological disorders
Discover how Neurosetta is enabling unprecedented disease modeling and quantitative high-throughput screening to uncover risk factors that can perturb neurodevelopment and cause neurological disorders.
Upcoming Events
Click below for more information.
Human Neurodevelopmental Screening, Simplified
Bring embryonic neurodevelopment within reach for scientific screening and discovery with RosetteArray® technology (Patent No. US 11,767,508). RosetteArray assays model embryonic brain and spinal cord development in micropatterned well plate culture, and assess substances or genetic backgrounds for risk of developmental disruptions, including developmental neurotoxicity or neurodevelopmental disorders.
Protecting human health is easier than ever before with RosetteArray technology.
Human Neurodevelopmental Screening, Simplified
Bring embryonic neurodevelopment within reach for scientific screening and discovery with RosetteArray® technology (Patent No. US 11,767,508). RosetteArray assays model embryonic brain and spinal cord development in micropatterned well plate culture, and assess substances or genetic backgrounds for risk of developmental disruptions, including developmental neurotoxicity or neurodevelopmental disorders.
Protecting human health is easier than ever before with RosetteArray technology.
Funding
The founding of Neurosetta was supported by the WARF Accelerator Program.
Collaborators
Scalable Cortical Organoid Manufacture
Tauopathy Screening
Neurodevelopmental Effects of Opioid Exposure
Developmental Neurotoxicity Screening
Funding
The founding of Neurosetta was supported by the WARF Accelerator Program.
Collaborators
Scalable Cortical Organoid Manufacture
Tauopathy Screening
Neurodevelopmental Effects of Opioid Exposure
Developmental Neurotoxicity Screening